The standard care for infection diagnosis can be cumbersome, slow, & often painful.
- Broad-spectrum antibiotics are nonspecific & can be ineffective or even harmful.
- Waiting for the lab test results gives the infection time to worsen, increasing patient length of stay & costing the healthcare system millions each year.
At Sensill™, we are developing a novel, breakthrough technology to diagnose infections rapidly & noninvasively, in real-time plus making diagnoses quantitative & inexpensive.
- With traditional techniques, identifying infectious microorganisms can take days, forcing patients to wait before they can receive their targeted antibiotics.
- Sensill technology will aim to rapidly (non-invasively, at the point of care) identify & quantify infectious microorganisms (bacteria or fungi) so the appropriate medication can be prescribed immediately after the initial diagnosis plus response to treatment can be monitored continuously until the infection has resolved.
Sensill analyzes volatile organic compounds in order to identify & quantify microorganisms.
Volatile organic compounds (VOCs) are emitted by all bacteria & fungi, each species having a signature combination of VOCs.
The olfactory systems of dogs are highly sensitive to VOCs, enabling them to detect anything from explosives & drugs to cancer & infection. A similar technological approach can be employed to assist doctors in the detection of the same VOCs.
Sensill is developing patented technology to identify specific microorganisms by their unique combinations of volatile organic compounds (VOCs).
Sensill is innovating technology to detect VOCs with a proprietary, noninvasive, point-of-care technology.
The Sensill™
Diagnostic System
Sensill is developing a diagnostic system that will allow doctors to rapidly & noninvasively diagnose skin and wound as well as urine infections, plus continuously monitor the response to therapy at the point of care.
Get in touch
Tour our site & contact us through our web form to get in touch. Feel free to learn more about our team on the about us page!
Sensill: Redefining Diagnostics.
Sensill is developing a diagnostic system to be:
1. Real-time
Sensill aims to provide immediate insights, allowing clinicians to make rapid decisions directly at the point of care without waiting for lab results.
2. Inexpensive
Sensill technology intends to help minimize the need for expensive skin biopsies with an economical solution.
3. Fast
Sensill aims to analyze emitted volatile organic compounds within minutes, identifying and quantifying infectious bacteria during the initial diagnosis.
4. Accurate
Sensill plans to provide an accurate identification and quantification of infectious bacteria or fungi, comparable to but more efficient than traditional methods.
5. Non-invasive
The Sensill diagnostic system intends to avoid skin biopsies, making it far easier than traditional care. It's designed to be an entirely non-invasive procedure.
6. Portable
The Sensill diagnostic system intends to be easy to carry between patients and battery-operated, making it ideal as a portable device.
7. Easy
The Sensill diagnostic system intends to be easy to use and operate by all health professionals.
8. Quantitative
Sensill aims to provide a quantitative metabolic readout reflecting the actual level of organism burden, which can help monitor treatment effectiveness.
9. Versatile
The platform is designed to be capable of detecting metabolite signatures from any living organism, offering unparalleled versatility beyond its initial focus on skin and urine infections.
10. Patented Technology
Sensill's validated platform is protected by 17 patents, ensuring a powerful and robust new standard in diagnostics.
11. Combats Antibiotic Resistance
By providing accurate identification and minimizing broad-spectrum antibiotic use, Sensill aims to contribute to a reduction in the rate of resistance development.
12. No Calibration Required
The system is designed to fit into the point-of-care workflow without requiring calibration.
13. Identifies Pathogens & Subspecies
Sensill demonstrates the ability to identify and quantify bacteria, fungi, and subspecies (e.g., MRSA).